![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 41, 38877-38883, October 11, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cell and Molecular Biology, Section of Cell
and Matrix Biology, Lund University, BMC, C13,
S-221 84 Lund, Sweden
New therapies based on gene transfer and
protein delivery require a better understanding of the
basic mechanisms of macromolecular membrane transport. We have
studied cellular uptake of macromolecular polyanions,
i.e. DNA and glycosaminoglycans, and a polybasic HIV-Tat derived peptide (GRKKRRQRRRPPQC) using fluorescence assisted cell sorting and confocal fluorescence microscopy. The transactivator of HIV
transcription (Tat) peptide stimulated cellular uptake of both DNA and
heparan sulfate in a time-, concentration-, and temperature-dependent manner. Peptide-polyanion complexes
accumulated in large, acidic, cytoplasmic vesicles formed de
novo. This was followed by transfer of polyanion into the
nuclear compartment and subsequent disappearance of the endolysosomal
vesicles. In the absence of polyanion the Tat peptide displayed rapid
accumulation in the nuclear compartment. However, in the presence of
polyanion the peptide was almost exclusively retained in cytoplasmic
vesicles. Cell-surface proteoglycans played a pivotal role in the
uptake of complexes exhibiting a relatively high peptide to polyanion ratio, corresponding to a net positive charge of the complexes. Uptake
of polyanions per se or complexes with a relatively low peptide to polyanion ratio was favored by proteoglycan deficiency in
the recipient cells, indicating the existence of distinct transport mechanisms. Moreover, expression of full-length HIV-Tat as well as
exogenous addition of HIV-Tat peptide resulted in cellular accumulation
of endogenous proteoglycans. We conclude that an HIV-Tat derived
peptide efficiently targets extraneous DNA and glycosaminoglycans to
the nuclear compartment and that proteoglycans serve a regulatory role
in these processes, which may have implications for directed gene and
drug delivery in vivo.
To whom correspondence should be addressed: Dept. of Cell and
Molecular Biology, Section of Cell and Matrix Biology, BMC, C13,
S-221 84, Lund, Sweden. Tel.: 46-46-2224077; Fax: 46-46-2223128; E-mail: Mattias.Belting@medkem.lu.se.
This article has been cited by other articles:
![]() |
M. Hashimoto, M. Taniguchi, S. Yoshino, S. Arai, and K. Sato S Phase-preferential Cre-recombination in Mammalian Cells Revealed by HIV-TAT-PTD-mediated Protein Transduction J. Biochem., January 1, 2008; 143(1): 87 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wittrup, S. Sandgren, J. Lilja, C. Bratt, N. Gustavsson, M. Morgelin, and M. Belting Identification of Proteins Released by Mammalian Cells That Mediate DNA Internalization through Proteoglycan-dependent Macropinocytosis J. Biol. Chem., September 21, 2007; 282(38): 27897 - 27904. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kobayashi, Y. Yamada, and T. Yoshida Nuclear Translocation Peptides as Antibiotics Antimicrob. Agents Chemother., March 1, 2006; 50(3): 1118 - 1119. [Full Text] [PDF] |
||||
![]() |
J. Dominguez-Bendala, D. Klein, M. Ribeiro, C. Ricordi, L. Inverardi, R. Pastori, and H. Edlund TAT-Mediated Neurogenin 3 Protein Transduction Stimulates Pancreatic Endocrine Differentiation In Vitro Diabetes, March 1, 2005; 54(3): 720 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Kibler, A. Miyazato, V. S. R. K. Yedavalli, A. I. Dayton, B. L. Jacobs, G. Dapolito, S.-j. Kim, and K.-T. Jeang Polyarginine Inhibits gp160 Processing by Furin and Suppresses Productive Human Immunodeficiency Virus Type 1 Infection J. Biol. Chem., November 19, 2004; 279(47): 49055 - 49063. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Jones, B. Yazzie, and C. R. Middaugh Polyanions and the Proteome Mol. Cell. Proteomics, August 1, 2004; 3(8): 746 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sandgren, A. Wittrup, F. Cheng, M. Jonsson, E. Eklund, S. Busch, and M. Belting The Human Antimicrobial Peptide LL-37 Transfers Extracellular DNA Plasmid to the Nuclear Compartment of Mammalian Cells via Lipid Rafts and Proteoglycan-dependent Endocytosis J. Biol. Chem., April 23, 2004; 279(17): 17951 - 17956. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Farrell, J. M. Lee, E.-C. Shin, M. Cebrat, P. A. Cole, and S. D. Hayward Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide PNAS, March 30, 2004; 101(13): 4625 - 4630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ziegler and J. Seelig Interaction of the Protein Transduction Domain of HIV-1 TAT with Heparan Sulfate: Binding Mechanism and Thermodynamic Parameters Biophys. J., January 1, 2004; 86(1): 254 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Belting, K. Mani, M. Jonsson, F. Cheng, S. Sandgren, S. Jonsson, K. Ding, J.-G. Delcros, and L.-A. Fransson Glypican-1 Is a Vehicle for Polyamine Uptake in Mammalian Cells: A PIVOTAL ROLE FOR NITROSOTHIOL-DERIVED NITRIC OXIDE J. Biol. Chem., November 21, 2003; 278(47): 47181 - 47189. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Console, C. Marty, C. Garcia-Echeverria, R. Schwendener, and K. Ballmer-Hofer Antennapedia and HIV Transactivator of Transcription (TAT) "Protein Transduction Domains" Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans J. Biol. Chem., September 12, 2003; 278(37): 35109 - 35114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fittipaldi, A. Ferrari, M. Zoppe, C. Arcangeli, V. Pellegrini, F. Beltram, and M. Giacca Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins J. Biol. Chem., September 5, 2003; 278(36): 34141 - 34149. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |